Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Thyroid Cancer Diagnostic Market: By Test Type, By Distribution and Region Forecast 2019-2030
Thyroid Cancer Diagnostic Market: By Test Type, By Distribution and Region Forecast 2019-2030
Thyroid Cancer Diagnostic Market size was valued at 2.5 billion in 2023 and is poised to grow at a CAGR of 5.6% from 2024-2030. Thyroid cancer is a type of cancer that occurs when abnormal cells begin to grow in the thyroid gland, responsible for the excretion of thyroid hormones. It is asymptotic in the early stage and progresses with the formation of a lump in the thyroid gland. If diagnosed in the early stage it can be treated easily. The market is expected to show significant growth over the forecast period owing to the increasing prevalence of thyroid cancer and technological advancements are expected to boost the market.
Imaging tests are mandatory in the diagnosis and confirmation of thyroid cancer, imaging test market is expected to dominate the market over the forecast period. Biopsy is the second most important diagnostic tool in thyroid cancer diagnosis and is expected to grow at a significant rate over the forecast period. The diagnostic imaging sector has shown technological advances in the last few years and is expected to grow in the forecasted period. A positron emission tomography (PET) scan is the latest technology in thyroid cancer diagnosis it takes 3-D color images that are used to determine the spread of cancer.
Study Period
2024-2030Base Year
2023CAGR
5.6%Largest Market
North AmericaFastest Growing Market
Asia Pacific
Market for thyroid cancer diagnostics driven by growing incidence of autoimmune diseases such as Graves disease and Hashimotos thyroiditis. Iodine deficiency is as a prime risk factor for the increase in prevalence of thyroid disorders, increase in incidences of thyroid diagnosis, which is expected to increase drive the market over the forecast period. Innovation and advancement in the testing technology and need for accurate diagnosis of thyroid cancer is also expected to boost the growth in the thyroid cancer diagnosis market.
North America dominates the market and is expected to continue to do so over the forecast period while Asia Pacific and Africa is expected to grow at significant rate due to increase in incidences of thyroid cancer, government policies, patients awareness, advancement in healthcare infrastructure and focus of the government on curbing the various types of cancer is expected to boost the thyroid diagnostic market.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market CAGR |
5.6% |
|
By Test Type |
|
|
By Distribution Channel |
|
|
By Region |
|
Download Free Sample Report
The global thyroid cancer diagnostic market size was valued at US$ 2.5 billion in 2023 and is projected to grow at a CAGR of 5.6% from 2024-2030
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
| 1. Executive Summary |
| 2. Global Thyroid Cancer Diagnostic Market Introduction |
| 2.1.Global Thyroid Cancer Diagnostic Market - Taxonomy |
| 2.2.Global Thyroid Cancer Diagnostic Market - Definitions |
| 2.2.1. Test Type |
| 2.2.2.Distribution Channel |
| 2.2.3.Region |
| 3. Global Thyroid Cancer Diagnostic Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global Thyroid Cancer Diagnostic Market Analysis, 2019-2023 and Forecast 2024-2030 |
| 4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Thyroid Cancer Diagnostic Market By Type, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 5.1. Ultrasound |
| 5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Radioiodine Scan |
| 5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Computed Tomography Scan |
| 5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. MRI Scan |
| 5.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. PET Scan |
| 5.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Blood Tests |
| 5.6.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 5.7. Biopsy |
| 5.7.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.7.3. Market Opportunity Analysis |
| 5.8. Other Tests |
| 5.8.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.8.3. Market Opportunity Analysis |
| 6. Global Thyroid Cancer Diagnostic Market By Distribution Channel, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 6.1. Hospital Associated Labs |
| 6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Independent Diagnostic Labs |
| 6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Diagnostic Imaging Centers |
| 6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Cancer Research Institutes |
| 6.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Others |
| 6.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7. Global Thyroid Cancer Diagnostic Market By Region, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific (APAC) |
| 7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Middle East and Africa (MEA) |
| 7.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Latin America |
| 7.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8. North America Thyroid Cancer Diagnostic Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 8.1. Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1.Ultrasound |
| 8.1.2.Radioiodine Scan |
| 8.1.3.Computed Tomography Scan |
| 8.1.4.MRI Scan |
| 8.1.5.PET Scan |
| 8.1.6.Blood Tests |
| 8.1.7.Biopsy |
| 8.1.8.Other Tests |
| 8.2. Distribution Channel Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1.Hospital Associated Labs |
| 8.2.2.Independent Diagnostic Labs |
| 8.2.3.Diagnostic Imaging Centers |
| 8.2.4.Cancer Research Institutes |
| 8.2.5.Others |
| 8.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1.United States of America (USA) |
| 8.3.2.Canada |
| 9. Europe Thyroid Cancer Diagnostic Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 9.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Ultrasound |
| 9.1.2.Radioiodine Scan |
| 9.1.3.Computed Tomography Scan |
| 9.1.4.MRI Scan |
| 9.1.5.PET Scan |
| 9.1.6.Blood Tests |
| 9.1.7.Biopsy |
| 9.1.8.Other Tests |
| 9.2. Distribution Channel Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Hospital Associated Labs |
| 9.2.2.Independent Diagnostic Labs |
| 9.2.3.Diagnostic Imaging Centers |
| 9.2.4.Cancer Research Institutes |
| 9.2.5.Others |
| 9.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Germany |
| 9.3.2.France |
| 9.3.3.Italy |
| 9.3.4.United Kingdom (UK) |
| 9.3.5.Spain |
| 9.3.6.Rest of EU |
| 10. Asia Pacific (APAC) Thyroid Cancer Diagnostic Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 10.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Ultrasound |
| 10.1.2.Radioiodine Scan |
| 10.1.3.Computed Tomography Scan |
| 10.1.4.MRI Scan |
| 10.1.5.PET Scan |
| 10.1.6.Blood Tests |
| 10.1.7.Biopsy |
| 10.1.8.Other Tests |
| 10.2. Distribution Channel Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Hospital Associated Labs |
| 10.2.2.Independent Diagnostic Labs |
| 10.2.3.Diagnostic Imaging Centers |
| 10.2.4.Cancer Research Institutes |
| 10.2.5.Others |
| 10.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.China |
| 10.3.2.India |
| 10.3.3.Australia and New Zealand (ANZ) |
| 10.3.4.Japan |
| 10.3.5.Rest of APAC |
| 11. Middle East and Africa (MEA) Thyroid Cancer Diagnostic Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Ultrasound |
| 11.1.2.Radioiodine Scan |
| 11.1.3.Computed Tomography Scan |
| 11.1.4.MRI Scan |
| 11.1.5.PET Scan |
| 11.1.6.Blood Tests |
| 11.1.7.Biopsy |
| 11.1.8.Other Tests |
| 11.2. Distribution Channel Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Hospital Associated Labs |
| 11.2.2.Independent Diagnostic Labs |
| 11.2.3.Diagnostic Imaging Centers |
| 11.2.4.Cancer Research Institutes |
| 11.2.5.Others |
| 11.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.GCC Countries |
| 11.3.2.South Africa |
| 11.3.3.Rest of MEA |
| 12. Latin America Thyroid Cancer Diagnostic Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Ultrasound |
| 12.1.2.Radioiodine Scan |
| 12.1.3.Computed Tomography Scan |
| 12.1.4.MRI Scan |
| 12.1.5.PET Scan |
| 12.1.6.Blood Tests |
| 12.1.7.Biopsy |
| 12.1.8.Other Tests |
| 12.2. Distribution Channel Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Hospital Associated Labs |
| 12.2.2.Independent Diagnostic Labs |
| 12.2.3.Diagnostic Imaging Centers |
| 12.2.4.Cancer Research Institutes |
| 12.2.5.Others |
| 12.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Brazil |
| 12.3.2.Mexico |
| 12.3.3.Rest of LA |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1. Abbott Laboratories |
| 13.2.2. Hoffmann-La Roche Ltd. |
| 13.2.3. Thermo Fisher Scientific Inc., |
| 13.2.4. Siemens AG |
| 13.2.5. Bio Rad Laboratories Inc. |
| 13.2.6. GE Healthcare |
| 13.2.7. Illumina, Inc. |
| 13.2.8. Koninklijke Philips N.V. |
| 13.2.9. Toshiba Medical Systems Corporation |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.